1. Home
  2. MATW vs KROS Comparison

MATW vs KROS Comparison

Compare MATW & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATW
  • KROS
  • Stock Information
  • Founded
  • MATW 1850
  • KROS 2015
  • Country
  • MATW United States
  • KROS United States
  • Employees
  • MATW N/A
  • KROS N/A
  • Industry
  • MATW Metal Fabrications
  • KROS Biotechnology: Pharmaceutical Preparations
  • Sector
  • MATW Telecommunications
  • KROS Health Care
  • Exchange
  • MATW Nasdaq
  • KROS Nasdaq
  • Market Cap
  • MATW 654.6M
  • KROS 558.9M
  • IPO Year
  • MATW 1994
  • KROS 2020
  • Fundamental
  • Price
  • MATW $25.30
  • KROS $14.53
  • Analyst Decision
  • MATW Strong Buy
  • KROS Buy
  • Analyst Count
  • MATW 1
  • KROS 13
  • Target Price
  • MATW $40.00
  • KROS $20.63
  • AVG Volume (30 Days)
  • MATW 206.0K
  • KROS 477.3K
  • Earning Date
  • MATW 08-05-2025
  • KROS 08-06-2025
  • Dividend Yield
  • MATW 3.87%
  • KROS N/A
  • EPS Growth
  • MATW N/A
  • KROS N/A
  • EPS
  • MATW N/A
  • KROS 0.11
  • Revenue
  • MATW $1,703,999,000.00
  • KROS $214,713,000.00
  • Revenue This Year
  • MATW N/A
  • KROS $5,006.76
  • Revenue Next Year
  • MATW N/A
  • KROS N/A
  • P/E Ratio
  • MATW N/A
  • KROS $132.80
  • Revenue Growth
  • MATW N/A
  • KROS 91657.70
  • 52 Week Low
  • MATW $18.50
  • KROS $9.12
  • 52 Week High
  • MATW $32.24
  • KROS $72.37
  • Technical
  • Relative Strength Index (RSI)
  • MATW 62.95
  • KROS 64.67
  • Support Level
  • MATW $24.17
  • KROS $13.26
  • Resistance Level
  • MATW $25.90
  • KROS $14.68
  • Average True Range (ATR)
  • MATW 0.98
  • KROS 0.41
  • MACD
  • MATW 0.17
  • KROS 0.12
  • Stochastic Oscillator
  • MATW 88.37
  • KROS 89.35

About MATW Matthews International Corporation

Matthews International Corp is a personal services company that provides brand solution services, memorialization products, and industrial products in the United States and Europe. The majority of Matthews' revenue is derived from its SGK Brand Solutions business, which provides brand development services, printing equipment, creative design services, and embossing tools to the consumer packaged goods and packaging industries. The company's Memorialization segment, which sells bronze and granite memorials, caskets, and cremation equipment to the cemetery and funeral home industries, also contributes an important amount. Maximum amount of Matthews' revenue is generated from sales made in the North America, while European customers also contribute a sizable percentage.

About KROS Keros Therapeutics Inc.

Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.

Share on Social Networks: